A Tenfold Oxytocin Programming Error Discovered at Handoff

Treat this as oxytocin hyperstimulation with a nonreassuring tracing first; the root cause analysis happens later.

1. Stop the infusion and disconnect the tubing at the pump so no residual drug infuses.
2. Reposition lateral, give an IV crystalloid bolus, check maternal blood pressure and pulse, and apply continuous fetal monitoring.
3. Call the provider and the charge nurse now; put anesthesia on notice. Report the actual dose delivered, the duration, and the current tracing.
4. Request terbutaline 250 mcg subcutaneously if tachysystole and decelerations persist - this is the specific treatment for hyperstimulation.
5. Examine the patient: cervical change, vaginal bleeding, new-onset constant pain, loss of station, or a rising baseline with a loss of variability could indicate uterine rupture or abruption. Also assess for pulmonary edema or water intoxication from the volume and antidiuretic effect of oxytocin.
6. Prepare for expedited delivery if the tracing does not recover; keep the OR aware until the strip is reassuring for several contractions.

At 20 mL/hr of 60 mU/mL she received roughly 900 mU over 45 minutes instead of about 90 mU - the fetal and uterine effects can outlast the infusion by an hour or more, so monitoring continues after the strip improves.

Disclosure. Tell the patient and her partner promptly, in plain language, what happened: 'The medication was running faster than it should have been. We caught it, we've stopped it, and here is what we are doing now.' Include an apology and a statement of what will happen next. Do not speculate about blame and do not promise outcomes. Disclosure is an ethical obligation and is expected by accreditors; concealment is the greater liability.

In the medical record: objective clinical facts - the ordered rate, the rate found, the duration, the time it was stopped, the fetal and maternal response, every notification with times, interventions, and the fact that the event was disclosed to the patient and family. Never write 'incident report filed' or your opinion about who was at fault.

In the event report, not the chart: the narrative of how the error occurred, staffing, the pump library, the order set, and any contributing system factors. Route it to risk management and follow state adverse-event reporting requirements.

Notify the provider of record, the charge nurse, the nurse manager, and risk management, and confirm the covering provider has documented an assessment of the patient.

Separate the behavior from the outcome, and ask what a reasonable nurse in this system would have done.

The behavior looks like at-risk behavior or a system-induced error, not recklessness. The order was written in mU/min while the pump is programmed in mL/hr - a unit conversion is required at the bedside every time. There was no independent double-check at initiation, and the wording 'that's how we always do it' signals a normalized workaround rather than a rogue act. A punitive response would be wrong here and would suppress reporting of the next error.

Accountability still exists: a required double-check that was knowingly skipped, or a pump alert deliberately overridden, would move this along the spectrum and change the response.

System fixes that actually work:

• Standardize the concentration and build an oxytocin drug library in the smart pump with hard dose limits in mU/min.
• Order sets that display both mU/min and mL/hr, with the calculated rate printed on the order.
• Mandatory independent two-nurse double-check at initiation and at every rate change, documented.
• A forcing function at handoff: the oncoming nurse verifies the pump against the order for every high-alert infusion.

The debrief should happen within 24 hours, with the nurse supported and included rather than investigated, and a follow-up mechanism so the report does not disappear.